Article

Biochemist joins National Academy of Sciences

Los Angeles—Wayne L. Hubbell, PhD, the Jules Stein Professor of Ophthalmology and professor of chemistry and biochemistry at the University of California, Los Angeles (UCLA) has been elected to the National Academy of Sciences (NAS).

Los Angeles-Wayne L. Hubbell, PhD, the Jules Stein Professor of Ophthalmology and professor of chemistry and biochemistry at the University of California, Los Angeles (UCLA) has been elected to the National Academy of Sciences (NAS).

He has focused his research on the relationship between the molecular structure of a protein and the conformational changes that control its function. He is particularly interested in membrane proteins that behave as "molecular switches," that are switched to an active state by a physical or chemical signal.

He also is investigating the structure and function of water-soluble proteins such as the lens protein and the family of retinoid-carrying proteins that transport vitamin A throughout photoreceptor cells.

In addition to Dr. Hubbell, the NAS boasts 11 scientists actively researching vision.

They are:

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) The Residency Report: Clinical insights from the iStent infinite trial
(Image credit: Ophthalmology Times) ASCRS 2025: Amar Shah, MD, on why hyperosmolar tear film before and after cataract surgery matters
(Image credit: Ophthalmology Times) ASCRS 2025: Deb Ristvedt, DO, on medications, lasers, and lifestyle in glaucoma management
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
(Image credit: Ophthalmology Times) ASCRS 2025: Parag Majmudar, MD, on bridging the gap between residency and real-world practice
© 2025 MJH Life Sciences

All rights reserved.